SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Jan 29 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian Pastor who wrote (85)4/22/1997 12:55:00 AM
From: FNS   of 965
 
Brian, .05 not good enough!

Lilly lowered sales forcasts for Reopro to 250 Mil, from 300 Mil. After the close CNTO reported earnings .05 vs a loss of .16.

It looks like the mean estimates were .04 with the high end at .09.

Beating the "street" by only a penny is not acceptable under current market sentiment...not to mention potential impact due to high dollar and lower 1997 earnings estimates! (I don't have forecasts yet.)

I hope CNTO management can step up to the plate with some good news before the analysts have a field day. In any event, let's hope the stock will hold and rebuild, based on new drugs in the pipeline and positive testing and approval.

FNS

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext